EPAS1 and metabolic disease: In this regard, maintaining appropriate activity of HIF-2α is crucial for preventing AT dysfunction in obesity, suggesting that enhancing HIF-2α activity in ATMs may be an attractive approach for treating metabolic disorders caused by obesity (98).